This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 November,
Sheraton Airport Brussels, Belgium

The Industry’s Leading Event in Europe to Accelerate Therapeutics to Market by Expediting R&D, Improving CMC Efficiency, and Building New Partnerships

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.

Announcing TIDES Europe as a Hybrid Event for 2021

To best meet the needs of both traveling and stay-at-home audiences, TIDES Europe 2021 will be a HYBRID event, combining a live experience at the Sheraton Airport Brussels and digital experiences that showcase all of the content from the live event with additional keynotes, panel discussions and meeting scheduling to be fully inclusive to those unable to attend in person.

Our commitment to your health & safety are a priority so all our events are run according to official government and local authority guidance in the first instance, as well as any venue or location-specific regulations. In addition, all events follow the ten Informa AllSecure priority commitments [Details].

KEY AREAS OF FOCUS

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES Europe 2021 hybrid program features 3 scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics and Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies

Macromolecular Drug Delivery

Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing

LOOKING FOR ADDITIONAL TRAINING OPPORTUNITIES?

Join us at one of our upcoming virtual TIDES training courses.

Informa training courses provide in-depth teaching and discussion about highly technical and scientific topics relevant to the TIDES community that can not be covered at a conference. With 6+ hours of dedicated instruction in a classroom-like (teacher/student) environment, a training course will offer you interactive opportunities with the instructor and fellow attendees so you can get your most pressing questions answered in a much more individualized setting.

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration

September 14-16 (Virtual)
Learn how to develop an evolving control strategy for your drug substance — from early development to registration. The course will also discuss the issues and risks that can be developed, addressed and mitigated during development

Introduction to Oligonucleotide Conjugate Strategies

October 26-28 (Virtual)
Understand how to best design oligonucleotide conjugates — from simple starting building blocks to the full oligonucleotide conjugate. With full consideration of the biological behavior of both the finished molecule and all of its individual components.

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. We have both physical or digital opportunities, so we can adjust to whatever you are looking for.

To begin building your custom sponsorship package today, contact:

(Companies A-I) Michael Dunnet | 857-504-6732 | Michael.Dunnet@Informa.com

(Companies J-Z) Michael Moriarty | 646-895-7412 | Michael.Moriarty@Informa.com

LOOKING TO PRESENT YOUR SCIENTIFIC RESEARCH?

At TIDES Europe 2021, you can sign up to present your very own poster! Any registered delegate is eligible to add a poster presentation to their registration. $150 charge for industry and $0 for Academic/Govt.

"All Access" In-Person Poster Presenters

  • Everything included in the "Digital Experience" pass option ->
  • Dedicated Space in the Exhibit/Poster Hall in Boston to share poster & answer questions with delegates
  • Dedicated Poster Viewing Times in-person during 15-16 November conference in Brussels

"Digital Experience" Poster Presenters

  • Dedicated Virtual Room for Your Poster 
  • PDF of Your Poster for Virtual Attendees to View & Download
  • Dedicated Poster Viewing Times Which Allow Attendees to Visit You in Your Virtual Poster Room to Discuss Your Poster in Real-Time
  • Ability to Have Face to Face (Shared Video) Virtual Meetings with Attendees Who Visit Your Poster Room

TIDES US 2020 Virtual Attendee

"Overall, the virtual sessions were better than live sessions.  I could see who was attending, more questions were put forward in the virtual format vs approaching a microphone. The virtual format allowed viewing of past sessions making it easier to see everything and keep up with other critical work activities."